FDA expands use of kidney cancer drug developed from UTSW research
June 15, 2026
June 15, 2026
DALLAS, Texas, June 15 -- The University of Texas Southwestern Medical Center posted the following news release:
* * *
FDA expands use of kidney cancer drug developed from UTSW research
*
Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug . . .
* * *
FDA expands use of kidney cancer drug developed from UTSW research
*
Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug . . .